Form 4: CSX SVP & CCO Receives Significant Equity Grant

Maryclare T. Kenney, CSX's SVP & CCO, was granted 9,379 restricted stock units and 46,759 stock options as part of the company's 2026-2028 Long-Term Incentive Plan.

Summary

• Maryclare T. Kenney, Senior Vice President and Chief Commercial Officer of CSX Corp, received equity awards on February 26, 2026.
• The awards include 9,379 restricted stock units (RSUs) and 46,759 stock options.
• These equity instruments were granted under the CSX Corporation 2026-2028 Long-Term Incentive Plan.
• The stock options have an exercise price of $42.65 per share and are set to expire on February 26, 2036.
• Both the restricted stock units and stock options will vest in three equal annual installments on February 26, 2027, February 26, 2028, and February 26, 2029.
• Following these transactions, Ms. Kenney's beneficial ownership includes 15,922 shares of common stock held directly, 3,428 shares indirectly through the CSX Corporation 401(k) Plan, and 4,154 shares indirectly through a Joint Revocable Trust.
• She also beneficially owns 46,759 derivative options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive commitment and aligns management incentives with long-term shareholder interests through performance-based compensation.

Positives

• The grant of restricted stock units and stock options aligns management's interests with those of shareholders, incentivizing long-term performance and value creation.
• The three-year vesting schedule for both RSUs and options promotes executive retention and encourages a sustained focus on the company's strategic objectives.

Future Outlook

This filing does not contain forward-looking statements or guidance beyond the specified vesting schedule and expiration date of the granted equity awards.

Industry Context

StockSavvy.ai notes that equity grants to senior executives like Maryclare T. Kenney are a standard practice across the transportation and logistics industry, serving to align executive compensation with long-term company performance and shareholder value creation. This practice is consistent with typical executive incentive structures seen in major railroad operators and other large publicly traded companies.

Stakeholder Impact

• Shareholders: The equity grant aligns the interests of a key executive with shareholders, potentially fostering better long-term performance and strategic decision-making.
• Employees: No direct impact on general employees is indicated by this specific filing, as it pertains to executive compensation.

Next Steps

• The first tranche of restricted stock units and options will vest on February 26, 2027.
• The second tranche of restricted stock units and options will vest on February 26, 2028.
• The third and final tranche of restricted stock units and options will vest on February 26, 2029.
• Stock options will expire on February 26, 2036, if not exercised.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a senior executive as part of a long-term incentive plan. While it signals continued alignment of management interests with shareholders, it does not present new information that would fundamentally alter the investment thesis for CSX, thus warranting a 'hold' recommendation based solely on this disclosure.

Keywords

CSX, Maryclare T. Kenney, SVP & CCO, Equity Grant, Restricted Stock Units, Stock Options, Insider Transaction, Form 4, Long-Term Incentive Plan, Executive Compensation